Developing a new way to make influenza vaccines more effectively
Integrated and Continuous Manufacturing of an Influenza Vaccine
This study is exploring a new way to make flu vaccines using cell-based technology instead of eggs, which could help produce vaccines faster and more effectively, making them better at protecting you against changing flu viruses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan Technological University NIH-funded |
| Lab location | 1 site (Houghton, United States) |
| Project ID | NIH-10694874 on NIH RePORTER |
What this research studies
This research focuses on creating a new manufacturing process for influenza vaccines that uses cell-based technology instead of traditional egg-based methods. By continuously producing virus-like particles (VLPs), the team aims to make the vaccine production faster and more adaptable to changing virus strains. This innovative approach could lead to lower production costs and a stronger immune response in patients. The research will involve designing and testing a novel manufacturing system that can quickly respond to influenza mutations.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals at high risk for influenza, such as the elderly, young children, and those with compromised immune systems.
Not a fit: Patients who are not at risk for influenza or who do not receive vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and affordable influenza vaccines, improving public health outcomes.
How similar studies have performed: Other research has shown promise in using cell-based vaccines, but this specific continuous manufacturing approach is relatively novel.
Where this research is happening
Houghton, United States
- Michigan Technological University — Houghton, United States (Active)
Researchers
- Principal investigator: Heldt, Caryn — Michigan Technological University
- Study coordinator: Heldt, Caryn
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.